CATALOGO DEI PRODOTTI DELLA RICERCA
IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.
EnglishCyclosporine-A is being used increasingly for immunosuppression in patients undergoing organ transplantation. Hepatotoxicity has been noted to occur in up to 20% of renal transplant recipients receiving the drug. The exact nature of this hepato-toxicity, however, has not been defined, although it has been manifested principally, if not exclusively, as elevated serum bilirubin levels. The authors have observed a similar elevation of serum bilirubin levels in cardiac transplant recipients receiving cyclosporine-A and prednisone for immunosuppression.
| Titolo: | Cholestasis in heart transplant recipients treated with cyclosporine. | |
| Autori: | ||
| Data di pubblicazione: | 1983 | |
| Rivista: | ||
| Abstract: | Cyclosporine-A is being used increasingly for immunosuppression in patients undergoing organ transplantation. Hepatotoxicity has been noted to occur in up to 20% of renal transplant recipients receiving the drug. The exact nature of this hepato-toxicity, however, has not been defined, although it has been manifested principally, if not exclusively, as elevated serum bilirubin levels. The authors have observed a similar elevation of serum bilirubin levels in cardiac transplant recipients receiving cyclosporine-A and prednisone for immunosuppression. | |
| Handle: | http://hdl.handle.net/11562/431658 | |
| Appare nelle tipologie: | 01.01 Articolo in Rivista |
File in questo prodotto:
Copyright © 2021